Ellison Institute of Technology led a $60m Series A round in Wild Bioscience.

Ellison Institute of Technology, an academic institution in Oxford, led a $60m Series A round in Wild Bioscience, a crop improvement company, with participation from Oxford Science Enterprises, Braavos Capital and the University of Oxford. “Advancing agriculture has limitless potential to help people and the planet. So to achieve meaningful, scalable impact, we need the right investors who are truly aligned with that big vision. I’m deeply grateful to EIT and to our current investors for sharing our excitement about what we’ve accomplished so far, and for their united support as we embark on this ambitious growth journey together,” Dr. Ross Hendron, Wild Bio Co-Founder and CEO.